دورية أكاديمية

Effects of green coffee extract supplementation on anthropometric indices, glycaemic control, blood pressure, lipid profile, insulin resistance and appetite in patients with the metabolic syndrome: a randomised clinical trial.

التفاصيل البيبلوغرافية
العنوان: Effects of green coffee extract supplementation on anthropometric indices, glycaemic control, blood pressure, lipid profile, insulin resistance and appetite in patients with the metabolic syndrome: a randomised clinical trial.
المؤلفون: Roshan, Hanieh, Nikpayam, Omid, Sedaghat, Meghdad, Sohrab, Golbon
المصدر: British Journal of Nutrition; 2/14/2018, Vol. 119 Issue 3, p250-258, 9p
مصطلحات موضوعية: ANTHROPOMETRY, APPETITE, BLOOD pressure, BLOOD sugar, BODY weight, COFFEE, DIETARY supplements, FASTING, GLYCOSYLATED hemoglobin, HOMEOSTASIS, INSULIN resistance, LIPIDS, OBESITY, PLANT extracts, METABOLIC syndrome, BODY mass index, RANDOMIZED controlled trials, WAIST circumference, GLYCEMIC control
مستخلص: This study was conducted to elucidate the effects of decaffeinated green coffee bean extract (GCE) on anthropometric indices, glycaemic control, blood pressure, lipid profile, insulin resistance and appetite in patients with the metabolic syndrome (Mets). Subjects were randomly allocated to consume 400 mg GCE or placebo capsules twice per d for 8 weeks. Both groups were advised to follow an energy balanced diet. After GCE supplementation, systolic blood pressure (SBP) significantly reduced compared with the placebo group (-13·76 (SD 8·48) v. -6·56 (SD 9·58) mmHg, P=0·01). Also, GCE treatment significantly reduced fasting blood glucose (FBS) (-5·15 (SD 60·22) v. 29·42 (SD 40·01) mg/dl (-0·28 (SD 3·34) v. 1·63 (SD 2·22) mmol/l); P=0·03) and homoeostatic model of assessment of insulin resistance in comparison to placebo (-1·41 (SD 3·33) v. 1·23 (SD 3·84), P=0·02). In addition, waist circumference (-2·40 (SD 2·54) v. -0·66 (SD 1·17) cm, P =0·009) and appetite score (-1·44 (SD 1·72) v. -0·2 (SD 1·32), P=0·01) of the individuals supplemented with GCE indicated a significant decline. Besides, weight and BMI reduction in the intervention group was almost twice as much as the placebo group; however, this discrepancy was marginally significant (weight: -2·08 (SD 2·11) v. -0·92 (SD 1·30) kg, P=0·05). No difference was observed in terms of glycated Hb (HbA1c) percentage and lipid profile parameters between the two groups. To sum up, GCE administration had an ameliorating effect on some of the Mets components such as high SBP, high FBS and Mets main aetiological factors including insulin resistance and abdominal obesity. Furthermore, GCE supplementation could reduce appetite level. [ABSTRACT FROM AUTHOR]
Copyright of British Journal of Nutrition is the property of Cambridge University Press and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00071145
DOI:10.1017/S0007114517003439